FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy.
Authors: Pyrzynska B., Dwojak M. , Zerrouqi A. , Morlino G., Zapala P., Miazek N., Zagozdzon A., Bojarczuk K., Bobrowicz M., Siernicka M., Machnicki M.M., Gobessi S., Barankiewicz J., Lech-Maranda E., Efremov D.G., Juszczynski P., Calado D., Golab J., Winiarska M.
Published in: OncoImmunology
Publication type: article
Subject areas: Immunology and Microbiology; Medicine
SJR best quartile: Q1